Form 8-K MARINUS PHARMACEUTICALS For: Dec 10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St set for tepid open as oil prices fall, Treasury yields rise
- Oil prices edge lower on easing fears over Saudi supply disruption
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Marinus Pharmaceuticals (MRNS) PT Raised to $22 at Ladenburg Thalmann
December 11, 2018 7:06 AM ESTLadenburg Thalmann analyst Michael Higgins raised the price target on Marinus Pharmaceuticals (NASDAQ: MRNS) to $22.00 (from $20.00) while maintaining a Buy rating.
... More